(63 days)
Not Found
No
The document describes a physical cranial orthosis and a 3D scanning method for capturing head shape. There is no mention of AI or ML being used in the design, modification, or application of the device, or in the processing of the 3D scan data beyond basic shape capture.
Yes.
The device is specifically designed to correct or improve cranial deformities in infants by applying mild pressure and redirecting head growth, which constitutes a therapeutic intervention.
No
The device is a cranial orthosis used to reshape an infant's head, not to diagnose a condition. It is a therapeutic or treatment device.
No
The device description clearly details physical components like plastic shells, foam liners, and Velcro straps, indicating it is a physical medical device, not software-only. While it utilizes a 3D scanner (which involves software), the core therapeutic device is a physical orthosis.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The STARband and STARlight are physical devices (cranial orthoses) that are worn externally on an infant's head. They work by applying pressure to reshape the skull.
- Intended Use: The intended use is to treat cranial deformities by physically modifying the head shape, not by analyzing biological samples.
- Device Description: The description details the materials and design of the orthosis and the process of creating a custom fit based on a 3D scan or impression. There is no mention of analyzing biological samples.
- Performance Studies: The performance studies focus on the accuracy of the 3D shape capture and the repeatability and reproducibility of the process, not on the diagnostic accuracy of a test.
The device is a medical device, specifically a cranial orthosis, but it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The STARband and STARlight are intended for medical purposes for use on infants from 3 to 18 months of age, with moderate-to-severe non-synostotic positional plagiocephaly, infants with plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads by applying mild pressure to prominent regions of the infant's cranium in order to improve cranial symmetry and/or shape. The devices are also indicated for infants from 3 to 18 months of age whose synostosis has been surgically corrected, but who still have moderate-to-severe cranial deformities including plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads.
Product codes
OAN, MVA
Device Description
The STARband and STARlight redirects the head growth to improve proportion and symmetry. The practitioner takes a plaster impression or 3-dimensional captured image of the infant's head to acquire the existing shape. The mold is sealed and filled with plaster or the 3-dimensional image is carved from a rigid polyurethane foam blank to create a positive model of the head shape. The positive model is modified to obtain greater symmetry and space in the areas of flattening. The STARband and STARlight provide total contact over the prominent or bossed areas of the baby's head to discourage growth there. Over the course of treatment, the inside of the band is further modified by the practitioner to provide space for growth to occur in the flat or depressed areas. The shape of the STARband and STARlight directs growth into the areas of least resistance and creates a precise pathway for the head shape to improve in symmetry and proportion.
The STARband and STARlight product families as it was released in K141842 are essentially still the same devices. The STARband Side Opening design and STARband Bi-Valve design is made with an outer shell of 5/32" polyethylene-polypropylene copolymer plastic with an inner liner made of 1/2" pelite polyethylene foam or 1/2" Aliplast foam (closed cell polyethylene). The STARlight Side Opening design and the STARlight Bi-Valve design are made of a plastic shell of 5/32" - 1/4" clear Surlyn or 1/8" - 7/32" Clear Co-Polyester. The STARlight PRO (Post-operative Remolding Orthosis) design is made of 1/4" to 3/8" clear Surlyn. Optional Aliplast (closed cell polyethylene) padding is available for the clear plastic bands and in addition, optional Reston (polyurethane - 3M Medical Product) foam is available for the STARlight PRO design.
The STARband Side Opening design and the STARlight Side Opening design has a top opening and a side opening. The band is held in place by a Velcro strap (1½" for STARband Side Opening and 1" for STARlight Side Opening) across the side opening. The STARlight PRO has two side openings, no top opening, and is held in place by a Velcro strap across each side opening. The STARlight Bi-Valve design and the STARband Bi-Valve design consist of two plastic shells that overlap with a sliding mechanism. The right and left overlap tabs are connected via a Velcro strap with chafe and loop.
The proposed device modification is the addition of a new 3-dimensional shape capture method, specifically, the Vorum Spectra™ 3D Scanner uses a high quality LED structured light projector and a single camera to detect the shape of the surface captured. This scanner utilizes LED light which is a non-coherent (i.e. non-laser) light source.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
LED structured light projector and a single camera (3-dimensional shape capture)
Anatomical Site
Infant's cranium / head
Indicated Patient Age Range
3 to 18 months of age
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Repeatability and Reproducibility (R&R) Analysis: The purpose of this test is to analyze the repeatability and reproducibility (components of precision) of the proposed shape capture device. The data obtained is compared to the casting process and the predicate device. Utilized uniform shapes with known dimensions that represent various sizes of pediatric patients between ages 3 to 18 months of age. Associated test parameters include A-P and M-L. Results: The shape capture device passed the acceptance criteria. The relevancy of the test determined substantial equivalence of the proposed shape capture device.
Cranial Shape Capture Accuracy Study: The purpose of this test is to analyze the accuracy of the proposed shape capture device. The data obtained is compared to the casting process and the predicate device. Utilized a representative cranial shape that possesses a predefined shape with known dimensions. Associated parameters analyzed include A-P, M-L, P-D, various radius parameters, squareness, and flatness. Results: The shape capture device passed the acceptance criteria for all parameters. The relevancy of the test determined substantial equivalence of the proposed shape capture device.
Material Biocompatibility Testing:
Surlyn: Closed Patch Sensitization (Not a Sensitizer, No Erythema or Edema Formation), Primary Dermal Irritation (Negligible Dermal Response), Cytotoxicity – Agar Diffusion (Non-cytotoxic).
Copolymer with Pelite Foam: Closed Patch Sensitization (Not a Sensitizer, No Erythema or Edema Formation), Primary Dermal Irritation (Negligible Dermal Response), Cytotoxicity – Agar Diffusion (Non-cytotoxic).
Copolymer with Aliplast Foam: Closed Patch Sensitization (Not a Sensitizer, No Erythema or Edema Formation), Primary Dermal Irritation (Negligible Dermal Response), Cytotoxicity – Agar Diffusion (Non-cytotoxic).
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5970 Cranial orthosis.
(a)
Identification. A cranial orthosis is a device that is intended for medical purposes to apply pressure to prominent regions of an infant's cranium in order to improve cranial symmetry and/or shape in infants from 3 to 18 months of age, with moderate to severe nonsynostotic positional plagiocephaly, including infants with plagiocephalic-, brachycephalic-, and scaphocephalic-shaped heads.(b)
Classification. Class II (special controls) (prescription use in accordance with § 801.109 of this chapter, biocompatibility testing, and labeling (contraindications, warnings, precautions, adverse events, instructions for physicians and parents)).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus, which is a symbol of medicine, with three figures intertwined to represent people. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus. The logo is black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 18, 2015
Orthomerica Products, Inc. Mr. David L. Hooper Manufacturing Engineer 6333 North Orange Blossom Trail Orlando, Florida 32810
Re: K151979
Trade/Device Name: STARband® and STARlight® Regulation Number: 21 CFR 882.5970 Regulation Name: Cranial Orthosis Regulatory Class: Class II Product Code: OAN, MVA Dated: July 15, 2015 Received: July 17, 2015
Dear Mr. Hooper:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Carlos L. Pena -S 同心
Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K151979
Device Name STARband® and STARlight®
Indications for Use (Describe)
The STARband and STARlight are intended for medical purposes for use on infants from 3 to 18 months of age, with moderate-to-severe non-synostotic positional plagiocephaly, infants with plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads by applying mild pressure to prominent regions of the infant's cranium in order to improve cranial symmetry and/or shape. The devices are also indicated for infants from 3 to 18 months of age whose synostosis has been surgically corrected, but who still have moderate-to-severe cranial deformities including plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
I. Applicant Information
| Name: | Orthomerica Products, Inc. |
|---|---|
| Address: | 6333 North Orange Blossom Trail |
| Orlando, FL 32810 | |
| Telephone: | (407) 290-6592 |
| Facsimile: | (407) 290-2419 |
FDA Establishment Registration Number
1058152
Contact Information
| Contact Person: | David Hooper, Manufacturing Engineer | |
|---|---|---|
| Address: | 6333 North Orange Blossom Trail | |
| Orlando, FL 32810 | ||
| Telephone: | (407) 290-6592 | |
| Facsimile: | (407) 290-2419 | |
| Email: | dhooper@orthomerica.com | |
| Date Prepared: | July 15th, 2015 |
II. Submission Information
| Type: | Traditional 510(k) Submission |
|---|---|
| Proprietary Name: | STARband® and STARlight® |
| Common Name: | Cranial Orthosis |
| Classification: | Class II (special controls); OAN; MVA; 21 CFR 882.5970 |
| Classification Name: | Cranial Orthosis |
III. Manufacturer Site
| Name: | Orthomerica Products, Inc. |
|---|---|
| Address: | 6333 North Orange Blossom Trail |
| Orlando, FL 32810 | |
| Telephone: | (407) 290-6592 |
| Facsimile: | (407) 290-2419 |
| FDA Establishment Registration Number: | 1058152 |
4
IV. Description of Device/Modification
The STARband and STARlight redirects the head growth to improve proportion and symmetry. The practitioner takes a plaster impression or 3-dimensional captured image of the infant's head to acquire the existing shape. The mold is sealed and filled with plaster or the 3-dimensional image is carved from a rigid polyurethane foam blank to create a positive model of the head shape. The positive model is modified to obtain greater symmetry and space in the areas of flattening. The STARband and STARlight provide total contact over the prominent or bossed areas of the baby's head to discourage growth there. Over the course of treatment, the inside of the band is further modified by the practitioner to provide space for growth to occur in the flat or depressed areas. The shape of the STARband and STARlight directs growth into the areas of least resistance and creates a precise pathway for the head shape to improve in symmetry and proportion.
The STARband and STARlight product families as it was released in K141842 are essentially still the same devices. The STARband Side Opening design and STARband Bi-Valve design is made with an outer shell of 5/32" polyethylene-polypropylene copolymer plastic with an inner liner made of 1/2" pelite polyethylene foam or 1/2" Aliplast foam (closed cell polyethylene). The STARlight Side Opening design and the STARlight Bi-Valve design are made of a plastic shell of 5/32" - 1/4" clear Surlyn or 1/8" - 7/32" Clear Co-Polyester. The STARlight PRO (Post-operative Remolding Orthosis) design is made of 1/4" to 3/8" clear Surlyn. Optional Aliplast (closed cell polyethylene) padding is available for the clear plastic bands and in addition, optional Reston (polyurethane - 3M Medical Product) foam is available for the STARlight PRO design.
The STARband Side Opening design and the STARlight Side Opening design has a top opening and a side opening. The band is held in place by a Velcro strap (1½" for STARband Side Opening and 1" for STARlight Side Opening) across the side opening. The STARlight PRO has two side openings, no top opening, and is held in place by a Velcro strap across each side opening. The STARlight Bi-Valve design and the STARband Bi-Valve design consist of two plastic shells that overlap with a sliding mechanism. The right and left overlap tabs are connected via a Velcro strap with chafe and loop.
The proposed device modification is the addition of a new 3-dimensional shape capture method, specifically, the Vorum Spectra™ 3D Scanner uses a high quality LED structured light projector and a single camera to detect the shape of the surface captured. This scanner utilizes LED light which is a non-coherent (i.e. non-laser) light source.
5
V. Statement of Indications and Intended Use
Statement of Indications:
The STARband and STARlight are intended for medical purposes for use on infants from 3 to 18 months of age, with moderate-to-severe non-synostotic positional plagiocephaly, including infants with plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads by applying mild pressure to prominent regions of the infant's cranium in order to improve cranial symmetry and/or shape. The devices are also indicated for adjunctive use for infants from 3 to 18 months of age whose synostosis has been surgically corrected, but who still have moderate-to-severe cranial deformities including plagiocephalic-, brachycephalic- and scaphocephalic-shaped heads.
Intended Use:
The STARband and STARlight are designed to treat infants with abnormal head shapes from age 3 to 18 months and is available by prescription only. Since growth is the driving factor in head shape correction, the infants wear the STARband or STARlight for approximately 23 hours per day. The most common head deformities are positional plagiocephaly, brachycephaly, and scaphocephaly. The STARband and STARlight have also been cleared to treat unresolved head deformities in patients who have undergone surgery to correct craniosynostosis. The same principles of cranial remolding apply to positional deformities and post-operative patients.
VI. Predicate Devices
- 트 STARband and STARlight, Cranial Orthosis, K151147
6
VII. Summary of Technological Characteristics
The Spectra 3D Scanner proposed in this 510(k) is an additional method to capture the infant's head shape for the fabrication of the STARband and STARlight Cranial Orthosis. The technological characteristics and the underlying principles of operation of the STARband and STARlight Cranial Orthosis shall remain exactly the same. The inclusion of the Spectra 3D Scanner is the focus of this submission and that change is indicated in Table 1 under the Approved 3-Dimensional Imaging Devices section.
| Feature | From K151147 | Proposed Device |
|---|---|---|
| Intended | ||
| Use | Maintains total contact over areas of | |
| bossing or protrusion and creates voids | ||
| over areas of depression or flattening to | ||
| redirect cranial growth toward greater | ||
| symmetry. | Maintains total contact over areas of | |
| bossing or protrusion and creates voids | ||
| over areas of depression or flattening to | ||
| redirect cranial growth toward greater | ||
| symmetry. | ||
| Materials | Material for STARband Side Opening | |
| design and STARband Bi-Valve design |
- Outer shell of 5/32" copolymer
plastic - An inner liner of 1/2" Pelite
polyethylene foam or 1/2"
Aliplast foam | Material for STARband Side Opening
design and STARband Bi-Valve design - Outer shell of 5/32" copolymer
plastic - An inner liner of 1/2" Pelite
polyethylene foam or 1/2"
Aliplast foam |
| | Material for STARlight Side Opening
design and STARlight Bi-Valve design - 5/32" - 1/4" clear Surlyn or 1/8" –
7/32" Clear Co-Polyester plastic
shell | Material for STARlight Side Opening
design and STARlight Bi-Valve design - 5/32" - 1/4" clear Surlyn or 1/8" -
7/32" Clear Co-Polyester plastic
shell |
| | Material for STARlight PRO design - 1/4" – 3/8" clear Surlyn | Material for STARlight PRO design
- 1/4" - 3/8" clear Surlyn |
| | Closure for Bivalve design - Sliding/Overlap closure system
- Chicago screw (or similar) for top
sliding mechanism - 1" Velcro strap
- 1" chafe buckle
- Speedy rivets | Closure for Bivalve design
- Sliding/Overlap closure system
- Chicago screw (or similar) for top
sliding mechanism - 1" Velcro strap
- 1" chafe buckle
- Speedy rivets |
| | Closure for STARband Side Opening
design - 1 ½" Velcro Strap
- 1 ½" chafe buckle
- A Gap Block made from ½" firm
Pelite polyethylene foam | Closure for STARband Side Opening
design - 1 ½" Velcro Strap
- 1 ½" chafe buckle
- A Gap Block made from ½" firm
Pelite polyethylene foam |
| Feature | From K151147 | Proposed Device |
| Closure for STARlight Side Opening
design and the STARlight PRO design: - 1" Velcro Strap
- 1" chafe buckle
- Optional tamper resistant strap
(qty 2 for the STARlight PRO
design) | Closure for STARlight Side Opening
design and the STARlight PRO design: - 1" Velcro Strap
- 1" chafe buckle
- Optional tamper resistant strap
(qty 2 for the STARlight PRO
design) | |
| Product
Design | Custom made cranial orthosis,
approximately 6 to 10oz in weight.
STARlight PRO weighs 12.5 to 18.5 oz. | Custom made cranial orthosis,
approximately 6 to 10oz in weight.
STARlight PRO weighs 12.5 to 18.5 oz. |
| Production | - Form orthosis from a positive
mold of infant's head - Positive mold is formed based
upon measurements of the infant's
head taken by an approved 3-
dimensional imaging device from
which a 3-dimensional image is
made or from a traditional plaster
cast - The 3-dimensional image is used
to produce a positive mold using a
5-axis routing machine | - Form orthosis from a positive
mold of infant's head - Positive mold is formed based
upon measurements of the infant's
head taken by an approved 3-
dimensional imaging device from
which a 3-dimensional image is
made or from a traditional plaster
cast - The 3-dimensional image is used
to produce a positive mold using a
5-axis routing machine |
| Approved 3-
Dimensional
Imaging
Devices | - STARscanner I - STARscanner II
- Omega Scanner
- scanGogh-II
- 3dMDhead System
- 3dMDcranial System
- 3dMDflex System
- SmartSoc System
- M4DScan/BodyScan System | - STARscanner I
- STARscanner II
- Omega Scanner
- scanGogh-II
- 3dMDhead System
- 3dMDcranial System
- 3dMDflex System
- SmartSoc System
- M4DScan/BodyScan System
- Spectra 3D Scanner |
| Testing | Repeatability and Reproducibility (R&R)
Analysis - Utilized uniform shapes with
known dimensions that represent
various sizes of pediatric patients
between ages 3 to 18 months of
age - Compared proposed device to cast
and predicate device - Associated parameters includes
A-P and M-L - Proposed device is substantially
equivalent to predicate device | Repeatability and Reproducibility (R&R)
Analysis - Utilized uniform shapes with
known dimensions that represent
various sizes of pediatric patients
between ages 3 to 18 months of
age - Compared proposed device to cast
and predicate device - Associated parameters includes
A-P and M-L - Proposed device is substantially
equivalent to predicate device
Cranial Shape Capture Accuracy Study |
| | Cranial Shape Capture Accuracy Study | |
| Feature | From K151147 | Proposed Device |
| | shape that possesses a predefined - shape with known dimensions
- Compared proposed device to cast
and predicate device - Associated Coordinate Planes (A-
P; M-L; P-D and various Radius
Parameters; Squareness; Flatness) - Proposed device is substantially
equivalent to predicate device | shape that possesses a predefined - shape with known dimensions
- Compared proposed device to cast
and predicate device - Associated Coordinate Planes (A-
P; M-L; P-D and various Radius
Parameters; Squareness; Flatness) - Proposed device is substantially
equivalent to predicate device |
| | Material Biocompatibility Testing - Cytotoxicity -Agar Diffusion
- Closed Patch Sensitization
- Primary Dermal Irritation | Material Biocompatibility Testing
- Cytotoxicity -Agar Diffusion
- Closed Patch Sensitization
- Primary Dermal Irritation |
Table 1 - Comparison of Predicate Device cleared in K151147 to the Proposed Device
7
8
The STARband and STARlight Cranial Orthosis have already received FDA 510(k) clearance under K151147 for being manufactured from a handheld 3-dimensional imaging device that utilizes a LED structured light projector and a single camera to capture the 3D image (Rodin M4Dscan System). The Spectra Scanner utilizes the same technology as the FDA 510(k) cleared M4Dscan System of a LED structured light projector and takes continuous 2D images from triangulated positions with a single camera for shape capture. Considering that STARband and STARlight are still the same device as it was in the predicate device and that the shape capture devices have the same technological characteristics; the STARband and STARlight Cranial Othosis are substantially equivalent to the predicate device. Table 2 below is a summary of the performance testing conducted on the Spectra and the results obtained when compared to the casting method as well as previously cleared shape capture devices for the STARband and STARlight.
9
| Test | Test Method Summary | Results |
|---|---|---|
| Repeatability and | ||
| Reproducibility | ||
| (R&R) Analysis | The purpose of this test is to analyze | |
| the repeatability and reproducibility | ||
| (components of precision) of the | ||
| proposed shape capture device. The | ||
| data obtained is compared to the | ||
| casting process and the predicate | ||
| device. | ||
| Utilized uniform shapes with known | ||
| dimensions that represent various sizes | ||
| of pediatric patients between ages 3 to | ||
| 18 months of age. Associated test | ||
| parameters include A-P and M-L. | The shape capture device passed | |
| the acceptance criteria. The | ||
| relevancy of the test determined | ||
| substantial equivalence of the | ||
| proposed shape capture device. | ||
| Cranial Shape | ||
| Capture Accuracy | ||
| Study | The purpose of this test is to analyze | |
| the accuracy of the proposed shape | ||
| capture device. The data obtained is | ||
| compared to the casting process and | ||
| the predicate device. | ||
| Utilized a representative cranial shape | ||
| that possesses a predefined shape with | ||
| known dimensions. Associated | ||
| parameters analyzed include A-P, M- | ||
| L, P-D, various radius parameters, | ||
| squareness, and flatness. | The shape capture device passed | |
| the acceptance criteria for all | ||
| parameters. The relevancy of the | ||
| test determined substantial | ||
| equivalence of the proposed shape | ||
| capture device. |
Table 2 - Performance Testing Summary for STARband and STARlight Cranial Orthosis
The STARband and STARlight are essentially the same Cranial Orthosis. The main difference between the STARband and STARlight are the materials used to produce them. The STARband and STARlight materials have been biocompatibility tested, and the results of the tests are listed below in Table 3.
10
| Material | Test | Results | Conclusion |
|---|---|---|---|
| Surlyn | Closed Patch | ||
| Sensitization | A score of 0.00/0.00 (Test/Control) was given for both Incidence and Severity in the 24 hour and 48 hour scoring interval. | Not a Sensitizer | |
| No Erythema or | |||
| Edema Formation | |||
| Surlyn | Primary Dermal | ||
| Irritation | Primary Irritation Index: 0.00 | Negligible Dermal | |
| Response | |||
| Surlyn | Cytotoxicity – | ||
| Agar Diffusion | Cell culture treated with test sample exhibited no reactivity (Grade 0). | Non-cytotoxic | |
| Copolymer with | |||
| Pelite Foam | Closed Patch | ||
| Sensitization | A score of 0.00/0.00 (Test/Control) was given for both Incidence and Severity in the 24 hour and 48 hour scoring interval. | Not a Sensitizer | |
| No Erythema or | |||
| Edema Formation | |||
| Copolymer with | |||
| Pelite Foam | Primary Dermal | ||
| Irritation | Primary Irritation Index: 0.06 | Negligible Dermal | |
| Response | |||
| Copolymer with | |||
| Pelite Foam | Cytotoxicity – | ||
| Agar Diffusion | Cell culture treated with test sample exhibited no reactivity (Grade 0). | Non-cytotoxic | |
| Copolymer with | |||
| Aliplast Foam | Closed Patch | ||
| Sensitization | A score of 0.00/0.00 (Test/Control) was given for both Incidence and Severity in the 24 hour and 48 hour scoring interval. | Not a Sensitizer | |
| No Erythema or | |||
| Edema Formation | |||
| Copolymer with | |||
| Aliplast Foam | Primary Dermal | ||
| Irritation | Primary Irritation Index: 0.00 | Negligible Dermal | |
| Response | |||
| Copolymer with | |||
| Aliplast Foam | Cytotoxicity – | ||
| Agar Diffusion | Cell culture treated with test sample exhibited slight reactivity (Grade 1) | Non-cytotoxic |
Table 3 - Biocompatibility Testing Summary for STARband and STARlight Cranial Orthosis
Summary and Conclusions of Non-Clinical Performance Data VIII.
The Spectra Scanner was evaluated for substantial equivalence. The scanner uses flashes of LED structured light which is equivalent to the flash from a consumer grade camera and is safe to use on infants without eye protection. The shape capture repeatability and reproducibility was evaluated and determined to be acceptable. An additional, Cranial Shape Capture Accuracy Study was performed concluding that the Spectra Scanner yields a product that is substantially equivalent to the predicate device. With sufficient accuracy and no concerns with the safety of the scanner, the Spectra 3D Scanner was determined to have a safety and effectiveness profile similar to the predicate device for capturing infant head shape data to manufacture the STARband and STARlight Cranial Orthosis.